Pfizer AG - Ibrance 75 mg, Hartkapseln | | 66138 | | 01 | | Ibrance 75 mg | | Hartkapseln | | L01EF01 | | Palbociclib | | 31.01.2017 | | |
| Composition | palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, E 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Palbociclibum | 75 mg |
| BAG: Principe actif | Concentr. |
---|
Palbociclibum | 75 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Rubrum) | | | Ammoniae Solutio | 28 | | Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Lacca | | Drucktinte | Lactose Monohydrate | 55.775 mg | | Magnesii Stearas | | | Sodium | 1.28 mg | | Per Centum | | | Pro Capsula | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | Simeticone | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 21 | 1973.56 | 2162.80 | A | LS | Oui |
|
|